Rosai-Dorfman disease (RDD), formerly called sinus histiocytosis with massive lymphadenopathy, is a non-neoplastic proliferative histiocytic disorder with behavior ranging from highly aggressive to spontaneous remission. Although the lymph nodes are more commonly involved, any organ can be affected. This study aimed to describe the features and the follow-up of a case of extranodal RDD. Our patient was a 39-year-old woman who was referred with an 11-month history of pain in the right maxilla. On clinical examination, some upper right teeth presented full mobility with normal appearance of the surrounding gingiva. Radiographic exams showed an extensive bone reabsorption and maxillary sinus filled with homogeneous tissue, which sometimes showed polypoid formation. An incisional biopsy demonstrated a diffuse inflammatory infiltrate rich in foamy histiocytes displaying lymphocytes emperipolesis. Immunohistochemistry showed positivity for CD68 and S-100, and negativity for CD3, CD20, and CD30. Such features were consistent with the RDD diagnosis. The patient was referred to a hematologist and corticotherapy was administrated for 6 months. RDD is an uncommon disease that rarely affects the maxilla. In the present case, the treatment was conservative, and the patient is currently asymptomatic after 5 years of follow-up.
INTRODUCTION
Rosai-Dorfman disease (RDD) or sinus histiocytosis with massive lymphadenopathy is a rare histiocytic disease of unknown etiology. Some studies have reported a relationship with autoimmune diseases, hematological malignancies, post-infectious conditions, and immune dysfunction. 1, 2 The most common clinical findings of RDD include extensive painless lymphadenopathy with fever, weight loss, anemia, night sweats, tonsillitis, nasal problems, and hepatosplenomegaly. 3 Extranodal involvement can occur in the head and neck, particularly in the paranasal sinus and the nasal cavity. Exclusive bone lesions are exceptionally rare and usually have an unpredictable clinical course. 4 The aim of this report is to describe a rare case of RDD affecting the maxilla in association with maxillary sinuses, mucosal thickening, and polypoid lesions. The differential diagnosis and prognosis are discussed.
Article / Clinical Case Report

CASE REPORT
A 39-year-old woman was seen at our institution complaining of teeth mobility and pain of the upper right teeth, which had lasted for 11 months. The patient was an artisan and addicted to marijuana. During the anamnesis, the patient denied any other symptoms or systemic alterations. On intra-oral evaluation, the clinical appearance of the upper teeth gingiva was normal (Figure 1 ). However, most of the upper teeth presented full mobility.
Radiographic exams showed a diffuse osteolytic image in the right maxilla with great destruction of the alveolar bone. The teeth had lost their bone support and presented characteristics of floating teeth. In addition, the lesion destroyed the cortical bone without the expansion of both the buccal and the palatal cortical plates. Polypoid lesions and mucosal thickening of both maxillary sinuses were also evident (Figures 2 and 3 ).
The main clinical diagnostic hypotheses were Langerhans cell histiocytosis (LCH), NK/T-cell lymphoma, and sinus carcinoma. An incisional biopsy of the alveolar bone (upper right canine) was performed, and the histopathological analysis showed an intense diffuse mononuclear cell infiltration rich in xanthomatous cells, some of which had evident emperipolesis of the lymphocytes. Areas of necrosis were also observed 
DISCUSSION
RDD is a rare disease of the hematopoietic system with approximately 1,000 cases reported in the English language literature as at 2012. The most common presentation is a painless cervical lymphadenopathy, but eventually the axillary and inguinal nodes become involved. Extranodal involvement is uncommon. However, skin, nasal cavity, and paranasal sinuses may be affected, along with systemic symptoms, such as fever, pain, weight loss, pharyngitis, and nasal obstruction. RDD can be found solely in the skeleton as isolated or multifocal osseous involvement. In the review by Foucar et al., 5 which involved 423 patients with RDD, 33 (7.8%) had osteolytic bone lesions and only 4 presented involvement of the jaw bones.
Paranasal sinuses represent one of the two most common extranodal sites of RDD. Polyps or mass lesions are commonly observed, and approximately 70% of these patients show concomitant extranodal site involvement, which often involve the eyelid/orbit, skin, or oral cavity. Similarly, in our case, both paranasal sinuses and maxilla were affected, eventually representing extension of the same disease, and the main complaint of the patient was the pain.
Cardoso et al. 6 reviewed the literature from 1969 to 2011 and found only eight cases of RDD affecting the maxillary bones (six females and two males, aged 18-56 years). In five of these patients, the maxilla was exclusively involved. In the present case, a 39-year-old woman referred intense pain in the region of the upper right maxilla. However, the pain was not associated with the teeth according to clinical, radiographic, and pulp vitality tests. X-ray and computed tomography showed an extensive osteolytic lesion involving the alveolar bone of the right maxilla, and bilateral sinusopathy. In addition, both the physical examination and the bone scintigraphy showed no other affected sites. RDD has nonspecific bone imaging findings that may be represented by ill-defined osteolytic or sclerotic lesions. Differential diagnosis of bone lesions includes LCH, metastatic tumor, osteomyelitis, lymphoma, and sarcoidosis. [7] [8] [9] RDD etiology is uncertain; some studies suggested an inappropriate response of the immune system to the Epstein-Barr virus (EBV) and human herpes virus-6 infections. In fact, high levels of serum antibodies against EBV were found in patients with RDD. 3, 10 Other studies pointed out the association between RDD and LCH, or considered RDD as an unusual variant of LCH. Interestingly, synchronous or metachronous RDD and LCH were reported in 10 patients. [11] [12] [13] Our patient had no systemic symptoms, except for a discrete anemia (hemoglobin 10.5g/dL [reference value: 12-14 mg/dL]).
The diagnosis of RDD was confirmed by histological and immunohistochemical studies. Macrophages exhibiting emperipolesis-expressing S-100 and CD1a-negative-can be considered almost 14 Such immunohistochemical characteristics were found in our case, which showed immunoreactivity for CD68, S-100, and CD3, and was negative for CD30 and CD1a. Furthermore, xanthomatous macrophages were also be observed.
There is no specific treatment for RDD. In a recent review dealing with a treatment strategy for RDD, 50% of patients did not require any treatment, while others received steroids, antibiotics, chemotherapy, radiation, surgery, and antifungal agents. 15 According to Keskin et al., 8 surgery appears to be one of the most effective approaches in the treatment of RDD. However, corticosteroid therapy reduces the fever and the lymphadenopathy and is usually the treatment of choice for controlling the disease. 15 In our case, corticotherapy was used in conjunction with a strict follow-up. The patient's maxillary pain was controlled, but the mobility of all teeth of the right maxilla remained unchanged, which required the extraction of some of them. After a 5-year follow-up, the patient is well, and the disease is considered under control without any further treatment requirement.
RDD affecting the maxillary bone is extremely rare and requires a close follow-up by the dentist together with the medical team, as it can cause severe bone destruction, plus teeth mobility and loss. Conservative treatment should be considered in such cases, taking into account the possibility of a spontaneous remission.
